Related Experiment Videos
Distalgesic; safety and efficacy. Efficacy: UK experience
Human Toxicology
|August 1, 1984
Summary
Distalgesic (dextropropoxyphene and acetaminophen) shows clinical utility for pain relief, but robust evidence from controlled trials is limited. Further long-term studies are needed to confirm its effectiveness in chronic pain management.
Area of Science:
- Pharmacology
- Clinical Trials
- Pain Management
Background:
- Distalgesic, a combination analgesic, has been used clinically for pain relief.
- Assessing analgesic efficacy in chronic pain presents significant methodological challenges.
- Existing research on Distalgesic efficacy has limitations in trial design.
Purpose of the Study:
- To review the UK's experience with Distalgesic efficacy.
- To critically evaluate the methodology of available clinical trials.
- To identify gaps in the evidence for chronic pain treatment.
Main Methods:
- Systematic review of 18 trials concerning Distalgesic efficacy.
- Detailed examination of three specific trials.
- Analysis of trial methodologies, including controlled and placebo-controlled designs.
Main Results:
- Only five of the 18 reviewed trials were controlled.
- A mere three trials incorporated a placebo control.
- Methodological weaknesses were identified in the assessed trials.
Conclusions:
- Distalgesic appears beneficial in clinical practice for pain management.
- High-quality, long-term controlled studies are lacking for chronic pain.
- Further research is required to establish definitive efficacy in chronic pain conditions.